These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
¨
|
|
Preliminary Proxy Statement
|
||
|
|
|
|||
|
¨
|
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
||
|
|
|
|||
|
x
|
|
Definitive Proxy Statement
|
||
|
|
|
|||
|
¨
|
|
Definitive Additional Materials
|
||
|
|
|
|||
|
¨
|
|
Soliciting Material Pursuant to §240.14a-12
|
||
|
|
||||
|
Yext, Inc.
|
||||
|
(Name of Registrant as Specified in Its Charter)
|
||||
|
|
||||
|
|
||||
|
(Name of Person(s) Filing Proxy Statement if other than the Registrant)
|
||||
|
|
||||
|
Payment of Filing Fee (Check the appropriate box):
|
||||
|
|
|
|||
|
x
|
|
No fee required.
|
||
|
|
|
|||
|
¨
|
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
||
|
|
|
|
||
|
|
|
1.
|
|
Title of each class of securities to which transaction applies:
|
|
|
|
|
|
|
|
|
|
2.
|
|
Aggregate number of securities to which transaction applies:
|
|
|
|
|
|
|
|
|
|
3.
|
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fees is calculated and state how it was determined):
|
|
|
|
|
|
|
|
|
|
4.
|
|
Proposed maximum aggregate value of transaction:
|
|
|
|
|
|
|
|
|
|
5.
|
|
Total fee paid:
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
¨
|
|
Fee paid previously with preliminary materials.
|
||
|
|
|
|||
|
¨
|
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
|
||
|
|
|
|
||
|
|
|
1.
|
|
Amount Previously Paid:
|
|
|
|
|
|
|
|
|
|
2.
|
|
Form, Schedule or Registration Statement No.:
|
|
|
|
|
|
|
|
|
|
3.
|
|
Filing Party:
|
|
|
|
|
|
|
|
|
|
4.
|
|
Date Filed:
|
|
|
|
|
|
|
|
Proposal
|
|
Board
Recommendation |
|
|
|
|
||
|
Election of Howard Lerman, Brian Distelburger and Julie Richardson as Class I directors
|
|
|
FOR
|
|
|
|
||
|
Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm
|
|
|
FOR
|
|
|
|
||
|
|
|
|
|
Time and Date
|
|
10:00 a.m. Eastern Time on June 12, 2018
|
|
Place
|
|
The New York Edition at 5 Madison Avenue, New York, New York 10010
|
|
Items of Business
|
|
1. To elect Howard Lerman, Brian Distelburger and Julie Richardson as Class I directors to hold office until our Annual Meeting of Stockholders in 2021 and until their respective successors have been elected or appointed;
2. To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending January 31, 2019; and
3. To transact any other business that may properly come before the Annual Meeting or any adjournment or postponement of the Annual Meeting.
|
|
Adjournments and Postponements
|
|
Any action on the items of business described above may be considered at the Annual Meeting at the time and on the date specified above or at any time and date to which the Annual Meeting may be properly adjourned or postponed.
|
|
Record Date
|
|
You are entitled to notice of and to vote at the Annual Meeting and at any adjournment or postponement that may take place only if you were a stockholder as of the close of business on April 19, 2018.
|
|
Proxy Materials and Annual Report
|
|
We are pleased to take advantage of Securities and Exchange Commission rules that allow us to furnish proxy materials and our Annual Report to stockholders on the Internet. On or around April 26, 2018, we will mail stockholders entitled to vote at the Annual Meeting a notice containing instructions on how to access these proxy materials and our Annual Report. The proxy materials and our Annual Report may also be accessed directly via the Internet at www.proxyvote.com using the control number located on your notice or proxy card.
|
|
Voting
|
|
Your vote is very important. Whether or not you plan to attend the Annual Meeting, we encourage you to read this proxy statement and submit your proxy or voting instructions as soon as possible. You may vote over the Internet or by telephone. In addition, if you requested printed copies of the proxy materials, you may submit your proxy or voting instruction card for the Annual Meeting by completing, signing, dating and returning your proxy or voting instruction card in the pre-addressed envelope provided. For specific instructions on how to vote your shares, please refer to the section entitled “Questions and Answers” beginning on page 1 of this proxy statement and the instructions on the proxy or voting instruction card. You can revoke a proxy prior to its exercise at the Annual Meeting by following the instructions in the accompanying proxy statement.
|
|
|
Page
|
|
Proxy Statement Questions and Answers
|
|
|
Directors and Corporate Governance
|
|
|
Executive Compensation
|
|
|
Executive Officers
|
|
|
Process and Procedure for Compensation Decisions
|
|
|
Fiscal 2018 Summary Compensation Table
|
|
|
Non-Equity Incentive Plan Compensation
|
|
|
Named Executive Officer Employment Arrangements
|
|
|
Outstanding Equity Awards at Fiscal 2018 Year End
|
|
|
401(k) Plan
|
|
|
Indemnification
|
|
|
Compensation of Non-Employee Directors
|
|
|
Beneficial Ownership of Shares of Common Stock
|
|
|
Section 16(a) Beneficial Ownership Reporting Compliance
|
|
|
Certain Relationships and Related Person Transactions
|
|
|
Policies and Procedures for Transactions with Related Persons
|
|
|
Transactions and Relationships with Directors, Officers and 5% Stockholders
|
|
|
Proposals Requiring Your Vote - Item 1 - Election of Class I Directors
|
|
|
Proposals Requiring Your Vote - Item 2 - Ratification of Independent Registered Public Accounting Firm
|
|
|
Transaction of Other Business
|
|
|
Requirements, Including Deadlines, for Submission of Proxy Proposals, Nomination of Directors and Other Business of Stockholders
|
|
|
•
|
elect Howard Lerman, Brian Distelburger and Julie Richardson as Class I directors to hold office until our Annual Meeting of Stockholders in 2021 and until their respective successors have been elected or appointed;
|
|
•
|
ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending January 31,
2019
; and
|
|
•
|
transact any other business that may properly come before the Annual Meeting or at any adjournment or postponement thereof.
|
|
•
|
FOR the election of Howard Lerman, Brian Distelburger and Julie Richardson as Class I directors; and
|
|
•
|
FOR the ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending January 31,
2019
.
|
|
•
|
written notice of revocation to the Corporate Secretary of the Company;
|
|
•
|
timely delivery of a valid, later-dated proxy or a later-dated vote by telephone or via the Internet; or
|
|
•
|
voting in person at the Annual Meeting.
|
|
Proposal
|
Vote required
|
Broker discretionary voting allowed?
|
|
Election of Class I directors
|
Plurality of votes cast
|
No
|
|
Ratification of appointment of independent auditors
|
Majority of votes cast
|
Yes
|
|
Name
|
|
Position(s)
|
|
Age
|
|
Nominees:
|
|
|
|
|
|
Howard Lerman
|
Chief Executive Officer, Class I Director
|
|
38
|
|
|
Brian Distelburger
|
President, Class I Director
|
|
39
|
|
|
Julie Richardson
(3)
|
Class I Director
|
|
54
|
|
|
Continuing Directors:
|
|
|
|
|
|
Michael Walrath
(1)(2)
|
Chairman and Class II Director
|
|
42
|
|
|
Phillip Fernandez
(1)(3)
|
Class II Director
|
|
57
|
|
|
Jesse Lipson
(1)
|
Class III Director
|
|
40
|
|
|
Andrew Sheehan
(2)(3)
|
Class III Director
|
|
60
|
|
|
Tamar Yehoshua
|
Class III Director
|
|
53
|
|
|
|
|
(1)
|
Member of the compensation committee.
|
|
(2)
|
Member of the nominating and governance committee.
|
|
(3)
|
Member of the audit committee.
|
|
•
|
appoint and oversee an independent registered public accounting firm and approve audit and non‑audit services;
|
|
•
|
evaluate the independence and qualifications of the independent registered public accounting firm at least annually;
|
|
•
|
review our annual audited consolidated financial statements and quarterly consolidated financial statements;
|
|
•
|
review the responsibilities, functions, qualifications and performance of our internal audit function, including our internal audit function’s charter, plans, budget, objectivity and the scope and results of internal audits;
|
|
•
|
approve the hiring, promotion, demotion or termination of the person in charge of our internal audit function;
|
|
•
|
review the results of the internal audit program, including significant issues in internal audit reports and responses by management;
|
|
•
|
review the hiring of employees or former employees of our independent registered public accounting firm;
|
|
•
|
review, approve and monitor related party transactions involving directors or executive officers and review and monitor conflicts of interest situations involving such individuals where appropriate;
|
|
•
|
periodically, meet separately with management, the internal auditors and our independent registered public accounting firm, both with and without management present, in each case to discuss any matters that the audit committee or others believe should be discussed privately;
|
|
•
|
address complaints we receive regarding accounting, internal accounting controls or auditing matters and procedures for the confidential, anonymous submission by our employees of concerns regarding questionable accounting or auditing matters;
|
|
•
|
review and discuss with management and our independent registered public accounting firm, on at least an annual basis, the overall adequacy and effectiveness of our legal, regulatory and ethical compliance programs, as well as reports regarding compliance with applicable laws, regulations and internal compliance programs;
|
|
•
|
discuss with management and our independent registered public accounting firm any correspondence with regulators or governmental agencies and any published reports that raise material issues regarding our financial
|
|
•
|
discuss with management and, as appropriate, our independent registered public accounting firm, the adequacy and effectiveness of our policies and practices regarding information technology risk management and the internal controls related to cybersecurity;
|
|
•
|
oversee management’s process for identifying, monitoring and addressing enterprise risks and evaluate and discuss its assessment of such enterprise risks with management, as well as oversee and monitor management’s plans to address such risks;
|
|
•
|
engage independent legal, accounting and other advisors as it determines necessary or appropriate to carry out its duties;
|
|
•
|
report regularly to the Board of Directors about issues including, but not limited to, any issues that arise with respect to the quality or integrity of our financial statements, our compliance with legal or regulatory requirements, the performance and independence of the independent registered public accounting firm and the performance of the internal audit function;
|
|
•
|
review at least annually the adequacy of the committee’s charter and recommend any proposed changes to the Board of Directors for approval; and
|
|
•
|
conduct and present to the Board of Directors an annual self‑performance evaluation of the committee.
|
|
•
|
establish, and periodically review, a general compensation strategy for our Company, and oversee the development and implementation of our compensation plans to ensure that these plans are consistent with this general compensation strategy;
|
|
•
|
administer all of our equity‑based plans and such other plans as shall be designated from time to time by the Board of Directors;
|
|
•
|
review, approve and determine, or make recommendations to our Board of Directors regarding, the compensation of our executive officers;
|
|
•
|
review and recommend to the Board of Directors the form and amount of compensation, including perquisites and other benefits, and any additional compensation to be paid, for service on the Board and Board committees and for service as a chairperson of a Board committee;
|
|
•
|
oversee regulatory compliance with respect to compensation matters affecting us;
|
|
•
|
retain or obtain the advice of compensation consultants, independent legal counsel and other advisers;
|
|
•
|
review and discuss with management the compensation discussion and analysis that we may be required to include in SEC filings from time to time;
|
|
•
|
prepare the compensation committee report on executive compensation that may be required by the SEC from time to time to be included in our annual proxy statements or annual reports on Form 10‑K filed with the SEC;
|
|
•
|
conduct and present to the Board of Directors an annual self‑performance evaluation of the committee; and
|
|
•
|
review at least annually the adequacy of the committee’s charter and recommend any proposed changes to the Board of Directors for approval.
|
|
•
|
make recommendations to the Board of Directors regarding the size and structure of the board, the composition of the board, the criteria for board membership and the process for filling vacancies on the board;
|
|
•
|
identify individuals qualified to become board members, after taking into consideration, if applicable, the criteria for board membership and recommend to the Board of Directors nominees to fill vacancies and newly created directorships and the nominees to stand for election as directors;
|
|
•
|
review the duties, composition and charters of the committees of the Board of Directors;
|
|
•
|
review and recommend to the Board of Directors our corporate governance principles and any proposed changes to such principles;
|
|
•
|
conduct and present to the Board of Directors an annual self‑performance evaluation of the committee;
|
|
•
|
oversee the evaluation of the Board of Directors, its committees and management and report such evaluation to the Board of Directors;
|
|
•
|
review and approve our Code of Business Conduct and Ethics, consider questions of possible conflicts of interest of board members and other corporate officers, review actual and potential conflicts of interest of board members and corporate officers, other than related party transactions reviewed by the audit committee, and approve or
|
|
•
|
review at least annually the adequacy of the committee’s charter and recommend any proposed changes to the Board of Directors for approval.
|
|
•
|
Howard Lerman, our Chief Executive Officer;
|
|
•
|
Steven Cakebread, our Chief Financial Officer; and
|
|
•
|
Tom Dixon, our Chief Technology Officer.
|
|
Name and Principal Position
|
|
Fiscal
Year |
|
Salary ($)
|
|
Stock Awards ($) (1) |
|
Option
Awards ($) (1) |
|
Non‑Equity
Incentive Plan Compensation ($) (2) |
|
All Other
Compensation ($) (3) |
|
Total ($)
|
|||||||||
|
Howard Lerman
|
2018
|
|
|
$469,780
|
|
|
|
$2,769,750
|
|
|
—
|
|
|
$287,000
|
|
|
$31,485
|
|
|
|
$3,558,015
|
|
|
|
Chief Executive Officer
|
2017
|
|
395,742
|
|
|
—
|
|
|
$3,608,988
|
|
125,000
|
|
24,078
|
|
|
4,153,808
|
|
||||||
|
Steven Cakebread
|
2018
|
|
419,643
|
|
|
923,250
|
|
|
6,063,083
|
|
129,833
|
|
21,982
|
|
|
7,557,791
|
|
||||||
|
Chief Financial Officer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Tom Dixon
|
2018
|
|
440,179
|
|
|
4,102,300
|
|
|
—
|
|
|
129,833
|
|
18,026
|
|
|
4,690,338
|
|
|||||
|
Chief Technology Officer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
|
|
(1)
|
The amounts in this column represent the aggregate grant‑date fair value of the award as computed in accordance with FASB ASC Topic 718. Such grant-date fair value does not take into account any estimated forfeitures related to service-based vesting conditions. The assumptions used in calculating the grant‑date fair value of the awards reported in this column are set forth in the notes to our audited consolidated financial statements included in our Annual Report on Form 10-K for the fiscal year ended January 31,
2018
. These amounts may not correspond to the actual value that may be received by the named executive officers.
|
|
(2)
|
The amounts reported represent the target amounts payable in the applicable fiscal year under our executive bonus plan, as described in greater detail under “—Non‑Equity Incentive Plan Compensation.”
|
|
(3)
|
The amounts reported represent 100% of the premiums paid for participation in our employee welfare benefits plan. We do not fully pay premiums for all employees.
|
|
•
|
100% of the named executive officer’s then‑outstanding and unvested time‑based equity awards will become vested and exercisable;
|
|
•
|
a lump sum cash amount equal to six months (18 months for Mr. Lerman) of the named executive officer’s base salary;
|
|
•
|
a lump sum cash amount equal to (x) 100% (150% for Mr. Lerman) of the named executive officer’s target annual bonus plus (y) the named executive officer’s target annual bonus as in effect for the fiscal year in which the named executive officer’s termination occurs but prorated based on the number of days the named executive officer was actually employed during the fiscal year; and
|
|
•
|
payment or reimbursement of continued health coverage for the named executive officer and the named executive officer’s dependents under COBRA for a period of up to six months (12 months for Mr. Lerman).
|
|
|
|
|
|
Option Awards
|
|
Stock Awards
|
|||||||||||||||
|
Named Executive Officer
|
|
Grant Date
|
|
Number of Securities Underlying Unexercised Options Exercisable (#) |
|
Number of
Securities Underlying Unexercised Options Unexercisable (#) |
|
Option Exercise Price ($) |
|
Option Expiration Date |
|
Number of
shares or units of stock that have not vested (#) |
|
Market value
of shares of units of stock that have not vested ($) |
|||||||
|
Howard Lerman
|
|
6/12/2017 (1)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
225,000
|
|
|
|
$2,711,250
|
|
|
|
|
4/28/2016 (2)
|
|
481,250
|
|
|
618,750
|
|
|
$6.11
|
|
4/28/2026
|
|
|
—
|
|
|
—
|
|
||
|
Steven Cakebread
|
|
12/21/2017 (3)
|
|
—
|
|
|
1,000,000
|
|
|
12.47
|
|
12/21/2027
|
|
|
—
|
|
|
—
|
|
||
|
|
|
6/12/2017 (1)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
75,000
|
|
|
903,750
|
|
|
|
|
|
4/28/2016 (2)
|
|
78,750
|
|
|
101,250
|
|
|
6.11
|
|
4/28/2026
|
|
|
—
|
|
|
—
|
|
||
|
|
|
9/10/2015 (4)
|
|
116,666
|
|
|
83,334
|
|
|
5.00
|
|
9/10/2025
|
|
|
—
|
|
|
—
|
|
||
|
|
|
10/23/2014 (5)
|
|
792,500
|
|
|
187,500
|
|
|
3.06
|
|
10/1/2024
|
|
|
—
|
|
|
—
|
|
||
|
Tom Dixon
|
|
12/21/2017 (6)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
250,000
|
|
|
3,012,500
|
|
|
|
|
|
6/12/2017 (7)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
80,000
|
|
|
964,000
|
|
|
|
|
|
4/28/2016 (2)
|
|
87,500
|
|
|
112,500
|
|
|
6.11
|
|
4/28/2026
|
|
|
—
|
|
|
—
|
|
||
|
|
|
5/31/2013 (8)
|
|
500,000
|
|
|
—
|
|
|
2.27
|
|
5/31/2023
|
|
|
—
|
|
|
—
|
|
||
|
|
|
3/2/2010 (9)
|
|
474,985
|
|
|
—
|
|
|
1.83
|
|
3/2/2020
|
|
|
—
|
|
|
—
|
|
||
|
(1)
|
One-seventh of the shares subject to award vests on June 20, 2019 and then quarterly thereafter on each of September 20, December 20, March 20 and June 20 thereafter, in each case subject to the executive's continued service on each such date, until the award is fully vested on December 20, 2020.
|
|
(2)
|
One-fourth of the shares subject to the option vested on April 22, 2017, and one thirty-sixth of the remaining shares subject to the option vest monthly thereafter, in each case subject to the executive’s continued service on each such date.
|
|
(3)
|
One-twentieth of the shares subject to award vests on March 20, 2018 and then quarterly thereafter on each of June 20, September 20, December 20 and March 20 thereafter, in each case subject to the executive's continued service on each such date, until the award is fully vested on December 20, 2022.
|
|
(4)
|
One-fourth of the shares subject to the option vested on September 10, 2016, and one thirty-sixth of the remaining shares subject to the option vest monthly thereafter, in each case subject to the executive’s continued service on each such date.
|
|
(5)
|
One-fourth of the shares subject to the option vested on October 1, 2015, and one thirty-sixth of the remaining shares subject to the option vest monthly thereafter, in each case subject to the executive’s continued service on each such date.
|
|
(6)
|
One-sixteenth of the shares subject to award vests on March 20, 2018 and then quarterly thereafter on each of June 20, September 20, December 20 and March 20 thereafter, in each case subject to the executive's continued service on each such date, until the award is fully vested on December 20, 2021.
|
|
(7)
|
One-eleventh of the shares subject to award vests on June 20, 2018 and then quarterly thereafter on each of September 20, December 20, March 20 and June 20 thereafter, in each case subject to the executive's continued service on each such date, until the award is fully vested on December 20, 2020.
|
|
(8)
|
One-fourth of the shares subject to the option vested on May 31, 2014, and one thirty-sixth of the remaining shares subject to the option vested monthly thereafter.
|
|
(9)
|
One-fourth of the shares subject to the option vested on March 2, 2011, and one thirty-sixth of the remaining shares subject to the option vested monthly thereafter.
|
|
Name
|
|
Fees Earned
or Paid in Cash (1) |
|
Stock
Awards ($) (2)(3) |
|
Total ($)
|
|||||
|
Michael Walrath
|
|
$49,065
|
|
|
$136,322
|
|
|
$185,387
|
|
||
|
Phillip Fernandez
|
44,062
|
|
|
136,322
|
|
180,384
|
|
||||
|
Jesse Lipson
|
30,043
|
|
|
136,322
|
|
166,365
|
|
||||
|
Jules Maltz
(4)
|
—
|
|
|
—
|
|
|
—
|
|
|||
|
Julie Richardson
|
40,057
|
|
|
136,322
|
|
176,379
|
|
||||
|
Andrew Sheehan
|
38,054
|
|
|
136,322
|
|
174,376
|
|
||||
|
Tamar Yehoshua
(5)
|
9,946
|
|
|
305,678
|
(6)
|
315,624
|
|
||||
|
|
|
(1)
|
Represents cash retainers earned during the fiscal year ended January 31,
2018
after our initial public offering when our Outside Director Compensation Policy, as described below, went into effect.
|
|
(2)
|
Represents the aggregate grant-date fair value of the awards as computed in accordance with FASB ASC Topic 718. Such grant-date fair value does not take into account any estimated forfeitures related to service-based vesting conditions. The assumptions used in calculating the grant-date fair value are set forth in the notes to our audited consolidated financial statements included in our Annual Report on Form 10-K for the fiscal year ended January 31,
2018
. These amounts may not correspond to the actual value that may be received by the independent directors.
|
|
(3)
|
All directors, other than Ms. Yehoshua, were granted 10,845 restricted stock units, or in the case of Mr. Walrath, restricted stock awards, on June 13, 2017. All of the shares subject to the awards shall vest on June 20, 2018, subject to the director's continued service to the Company on such date.
|
|
(4)
|
Mr. Maltz served as a director until his resignation in March 2017.
|
|
(5)
|
Ms. Yehoshua joined the Board of Directors on October 2, 2017.
|
|
(6)
|
Represents the aggregate grant-date fair value of 22,727 restricted stock units granted in connection with Ms. Yehoshua joining the Board of Directors on October 2, 2017. One-third of the shares subject to award shall vest on October 2, 2018, and then annually thereafter on each October 2, subject to Ms. Yehoshua's continued service to the Company on such date until the award is fully vested on October 2, 2020.
|
|
Name
|
|
Option Awards (#)
|
|
Stock Awards (#)
|
|
||
|
Michael Walrath
|
1,572,538
|
|
|
12,690
|
|
(1)
|
|
|
Phillip Fernandez
|
200,000
|
|
|
12,502
|
|
(2)
|
|
|
Jesse Lipson
|
—
|
|
|
10,845
|
|
|
|
|
Jules Maltz
|
—
|
|
|
—
|
|
|
|
|
Julie Richardson
|
245,000
|
|
|
10,845
|
|
|
|
|
Andrew Sheehan
|
—
|
|
|
10,845
|
|
|
|
|
Tamar Yehoshua
|
|
|
|
22,727
|
|
|
|
|
|
|
(1)
|
Includes 1,845 restricted stock awards received in lieu of cash compensation.
|
|
(2)
|
Includes 1,657 restricted stock units received in lieu of cash compensation.
|
|
•
|
$30,000 per year for service as a member of our Board of Directors;
|
|
•
|
$20,000 per year additionally for service as chair of our Board of Directors;
|
|
•
|
$20,000 per year additionally for service as chair of the audit committee;
|
|
•
|
$10,000 per year additionally for service as a member of the audit committee (other than chair);
|
|
•
|
$15,000 per year additionally for service as chair of the compensation committee;
|
|
•
|
$7,500 per year additionally for service as a member of the compensation committee (other than chair);
|
|
•
|
$7,500 per year additionally for service as chair of the nominating and corporate governance committee; and
|
|
•
|
$3,750 per year additionally for service as a member of the nominating and corporate governance committee (other than chair).
|
|
•
|
each beneficial owner of 5% or more of the outstanding shares of our common stock;
|
|
•
|
each of our directors;
|
|
•
|
each of our named executive officers; and
|
|
•
|
all directors and executive officers as a group.
|
|
Name of Beneficial Owner
|
|
|
Number of Shares
Beneficially Owned |
Percent of Shares Outstanding
|
||
|
Directors and Named Executive Officers:
|
|
|
||||
|
Howard Lerman
(1)
|
7,247,462
|
|
7.6
|
%
|
||
|
Steven Cakebread
(2)
|
1,027,916
|
|
1.1
|
|
||
|
Tom Dixon
(3)
|
1,016,915
|
|
1.1
|
|
||
|
Michael Walrath
(4)
|
3,625,105
|
|
3.7
|
|
||
|
Brian Distelburger
(5)
|
5,012,437
|
|
5.2
|
|
||
|
Phillip Fernandez
(6)
|
105,555
|
|
*
|
|
||
|
Jesse Lipson
|
303,845
|
|
*
|
|
||
|
Julie Richardson
(7)
|
312,500
|
|
*
|
|
||
|
Andrew Sheehan
(8)
|
1,831,932
|
|
1.9
|
|
||
|
Tamar Yehoshua
|
—
|
|
*
|
|
||
|
All executive officers and directors (11 persons)
(9)
|
20,898,417
|
|
20.8
|
|
||
|
Five Percent Stockholders:
|
|
|
||||
|
Entities and individuals affiliated with FMR LLC
(10)
|
10,946,049
|
|
11.5
|
|
||
|
Entities and individuals affiliated with Insight Venture Partners
(11)
|
7,710,621
|
|
8.1
|
|
||
|
Brent Metz
(12)
|
6,470,806
|
|
6.8
|
|
||
|
|
|
*
|
Represents beneficial ownership of less than 1%.
|
|
(1)
|
Includes
572,916
shares subject to options that are immediately exercisable or exercisable within 60 days of
March 31
,
2018
.
|
|
(2)
|
Includes
1,027,916
shares subject to options that are immediately exercisable or exercisable within 60 days of
March 31
,
2018
.
|
|
(3)
|
Includes
979,151
shares subject to options that are immediately exercisable or exercisable within 60 days of
March 31
,
2018
.
|
|
(4)
|
Consists of (a) 2,034,769 shares held by a limited liability company over which Mr. Walrath has sole voting and dispositive control, (b) 17,798 shares of restricted stock, of which 12,690 shares vest on June 20, 2018 and 5,108 shares vest on March 20, 2019 and (c) 1,572,538 shares subject to options and warrants held by Mr. Walrath that are immediately exercisable or exercisable within 60 days of
March 31
,
2018
.
|
|
(5)
|
Includes
260,416
shares subject to options that are immediately exercisable or exercisable within 60 days of
March 31
,
2018
.
|
|
(6)
|
Includes
105,555
shares subject to options that are immediately exercisable or exercisable within 60 days of
March 31
,
2018
.
|
|
(7)
|
Includes (a)
245,000
shares subject to options that are immediately exercisable or exercisable within 60 days of
March 31
,
2018
, (b) 15,000 shares held by the Jack Douglas Richardson 2010 Trust, of which Ms. Richardson is a trustee, (c) 26,250 shares held by the Charles Matthew Richardson 2006 Trust, of which Ms. Richardson is a trustee, and (d) 26,250 shares held by the Lucas Matthew Richardson 2008 Trust, of which Ms. Richardson is a trustee.
|
|
(8)
|
Consists of (a) 1,000,000 shares held by Tippet Venture Partners II, L.P. , a limited partnership controlled by Mr. Sheehan as the managing director of its general partner, (b) 447,048 shares held by Tippet Venture Partners, L.P., a limited partnership controlled by Mr. Sheehan as the managing director of its general partner, (c) 263,671 shares held by the Sheehan 2003 Trust, of which Mr. Sheehan is a co‑trustee, (d) 78,140 shares held by Sutter Hill Management Company, L.L.C. ("SHM") and (e) 43,073 shares held by Sutter Hill Ventures, a California Limited Partnership ("SHV"). SHV has voting and dispositive power over the shares held by SHM, and Mr. Sheehan is a trustee of a trust which is a member of SHM. The shares held by SHV are held as a nominee on behalf of, and for the exclusive benefit of, a trust (of which Mr. Sheehan is a trustee), which is a member of the general partner of SHV. The address of these beneficial owners is 755 Page Mill Road, Suite A-200, Palo Alto, California 94304-1005.
|
|
(9)
|
Includes
5,178,242
shares subject to options that are immediately exercisable or exercisable within 60 days of the Beneficial Ownership Date.
|
|
(10)
|
Based on a Schedule 13G/A filed with the SEC on February 13, 2018, FMR LLC may be deemed to beneficially own 10,946,049 shares, with the sole the power to vote or direct the vote of 190 shares and the sole power to dispose or to direct the disposition of 10,946,049 shares. The address for this beneficial owner is 245 Summer Street, Boston, Massachusetts 02210.
|
|
(11)
|
Based on a Schedule 13G filed with the SEC on February 12, 2018, consists of (i) 4,784,654 shares held of record by Insight Venture Partners VIII, L.P.; (ii) 1,237,656 shares held of record by Insight Venture Partners (Cayman) VIII, L.P.; (iii) 170,760 shares held of record by Insight Venture Partners VIII (Co‑Investors), L.P.; and (iv) 1,517,551 shares held of record by Insight Venture Partners (Delaware) VIII, L.P. Insight Holdings Group, LLC (“Holdings”) is the sole shareholder of Insight Venture Associates VIII, Ltd. (“IVA Ltd”). IVA Ltd is the general partner of Insight Venture Associates VIII, L.P. (“IVA LP”), which is the general partner of Insight Venture Partners VIII, L.P., Insight Venture Partners (Cayman) VIII, L.P., Insight Venture Partners VIII (Co‑Investors), L.P. and Insight Venture Partners (Delaware) VIII, L.P. (collectively “Fund VIII”). Holdings, IVA Ltd. and IVA LP have shared power to vote and dispose of the shares. The address for these beneficial owners c/o Insight Venture Partners, 1114 Avenue of the Americas, 36th Floor, New York, NY, 10036.
|
|
(12)
|
Based on a Schedule 13G filed with the SEC on January 10, 2018. The address for this beneficial owner is c/o Kleinberg, Kaplan, Wolff & Cohen, P.C., 551 Fifth Avenue, 18th Floor, New York, New York 10176.
|
|
•
|
any breach of their duty of loyalty to the corporation or its stockholders;
|
|
•
|
acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law;
|
|
•
|
unlawful payments of dividends or unlawful stock repurchases or redemptions; or
|
|
•
|
any transaction from which the director derived an improper personal benefit.
|
|
|
2017
|
|
2018
|
||||
|
Audit fees
(1)
|
$
|
2,434,370
|
|
|
$
|
1,058,686
|
|
|
Audit-related fees
(2)
|
229,817
|
|
|
103,086
|
|
||
|
Tax fees
|
—
|
|
|
—
|
|
||
|
All other fees
|
—
|
|
|
—
|
|
||
|
Total fees
|
$
|
2,664,187
|
|
|
$
|
1,161,772
|
|
|
(1) Audit fees consisted principally of work performed in connection with the audit of our consolidated financial statements included in our periodic filings and registration statements, review of our quarterly financial statements and services that are normally provided by the independent registered public accountants in connection with statutory and regulatory filings or engagements for those fiscal years.
(2) Audit-related fees consisted principally of services rendered in connection with service organization control examinations.
|
|||||||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|